Johnson & Johnson
Pharmaceuticals / Personal Products / Medical Equipment
JNJ
$ 183 0.15
Share price
$ 480 bn
Market Cap
$ 476 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
Johnson & Johnson aims to reduce Scope 1 + 2 by 60% by 2030 from a base year 2016
1.5°C
GHG emissions and Carbon intensity
Johnson & Johnson reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 748 Kt (-186 /-19.9% y-o-y). Also positively, carbon intensity dropped to 9.1 t (-2.3 /-20.2% y-o-y).
Johnson & Johnson's Scope 3 emissions declined marginally to 20,373 Kt (
The company is committed to reducing Scope 1 + 2 by 60% by 2030 from a base year 2016, which translates into the estimated reduction of -28 Kt per annum over the period of FY2021 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.
Copyright © 2022 Exerica. All rights reserved.